Assessing the Impact of 89Zr-Girentuximab PET/CT on Stated Management Preferences: Results from an Exploratory Survey of Urologic Oncologists

Clinical Genitourinary Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles